Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cheng Wang(Gansu Provincial Maternal and Child Health Hospital), George Lau(Humanity & Health), Jinlin Hou(Southern Medical University), Dong Ji(Humanity & Health), Vanessa Wu(Humanity & Health), April Wong(Humanity & Health), Xiaoyong Zhang(South China Agricultural University), Yudong Wang(Shanxi University), Jialiang Liu(Beijing Tsinghua Chang Gung Hospital), Jing Chen(Chinese Academy of Sciences), Bing Li(University of Wisconsin–Madison), Zheng Zhang(Hebei Agricultural University), Lei Lu(Humanity & Health), Guofeng Chen(Second Affiliated Hospital of Zhejiang University), Chris Wong(Université Claude Bernard Lyon 1), Jian Sun(Nanfang Hospital), Qing Shao(302 Military Hospital of China), Stella Tsang
Cited by 197
Related Papers
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
|New England Journal of Medicine|2005|1.5k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
|Journal of Allergy and Clinical Immunology|2020|694